Doctors at Memorial Sloan Kettering are constantly working to improve treatment for salivary gland cancer through research studies called clinical trials. Participating in a clinical trial may give you access to treatments that are not widely available elsewhere. A clinical trial may offer you additional options if your cancer has returned after standard treatment.
For salivary gland cancers, our doctors are running clinical trials testing in these areas:
- new drug therapies to boost the effectiveness of care
- safer and more-effective approaches to radiation therapy
- strategies for preserving the quality of life during and after treatment
For people with advanced disease, we offer a genomic test called MSK-IMPACT™. The test, developed by MSK experts, currently screens for more than 450 genetic mutations linked to cancer, and we continue to identify more.
Based on which mutations we find in your tumor, we may be able to offer you a clinical trial testing a drug designed to work against those mutations.
Our experts can help determine which clinical trials are right for you. Browse our listing of clinical trials that are currently enrolling new patients.
